Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Ma...
How could this publication affect Bionano’s intellectual‑property position or lead to new patents?
What risks or limitations were identified in the study that could affect commercial adoption (e.g., sample requirements, turnaround time, data analysis complexity)?
Will the results impact Bionano’s current guidance or lead to an update of its earnings forecasts?
Symbol:
BNGO
about 1 month ago